Related references
Note: Only part of the references are listed.The ubiquitinase ZFP91 promotes tumor cell survival and confers chemoresistance through FOXA1 destabilization
Dong-E. Tang et al.
CARCINOGENESIS (2020)
A Novel Redox Modulator Induces a GPX4-Mediated Cell Death That Is Dependent on Iron and Reactive Oxygen Species
Shuai Hu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Cereblon Modulators Target ZBTB16 and Its Oncogenic Fusion Partners for Degradation via Distinct Structural Degrons
Mary E. Matyskiela et al.
ACS CHEMICAL BIOLOGY (2020)
Cereblon versus VHL: Hijacking E3 ligases against each other using PROTACs
Miriam Girardini et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
CanStem111P trial: a Phase III study of napabucasin plus nab-paclitaxel with gemcitabine
Mohamad Bassam Sonbol et al.
FUTURE ONCOLOGY (2019)
Evaluation of Tumor Cell-Tumor Microenvironment Component Interactions as Potential Predictors of Patient Response to Napabucasin
An-Yun Chang et al.
MOLECULAR CANCER RESEARCH (2019)
GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2019)
Bioactivation of Napabucasin Triggers Reactive Oxygen Species-Mediated Cancer Cell Death
Fieke E. M. Froeling et al.
CLINICAL CANCER RESEARCH (2019)
Simple Structural Modifications Converting a Bona fide MDM2 PROTAC Degrader into a Molecular Glue Molecule: A Cautionary Tale in the Design of PROTAC Degraders
Jiuling Yang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Proteolysis Targeting Chimeras for the Selective Degradation of Mcl-1/Bcl-2 Derived from Nonselective Target Binding Ligands
Ziqian Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo
Longchuan Bai et al.
CANCER CELL (2019)
A novel series of napabucasin derivatives as orally active inhibitors of signal transducer and activator of transcription 3 (STAT3)
Chungen Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Discovery of MD-224 as a First-in-Class, Highly Potent, and Efficacious Proteolysis Targeting Chimera Murine Double Minute 2 Degrader Capable of Achieving Complete and Durable Tumor Regression
Yangbing Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Discovery of ARD-69 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor (AR) for the Treatment of Prostate Cancer
Xin Han et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Structure-Based Discovery of SD-36 as a Potent, Selective, and Efficacious PROTAC Degrader of STAT3 Protein
Haibin Zhou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Multi-omics profiling reveals key signaling pathways in ovarian cancer controlled by STAT3
Tiangong Lu et al.
THERANOSTICS (2019)
E2F is required for STAT3-mediated upregulation of cyclin B1 and Cdc2 expressions and contributes to G2-M phase transition
Jingjie Sun et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2019)
Translation Termination Factor GSPT1 Is a Phenotypically Relevant Off-Target of Heterobifunctional Phthalimide Degraders
Mette Ishoey et al.
ACS CHEMICAL BIOLOGY (2018)
Design, synthesis and activity of BBI608 derivatives targeting on stem cells
Qifan Zhou et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon
Afua A. Akuffo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Napabucasin and Related Heterocycle-Fused Naphthoquinones as STAT3 Inhibitors with Antiproliferative Activity against Cancer Cells
Hauke Loecken et al.
JOURNAL OF NATURAL PRODUCTS (2018)
Therapeutic developments in pancreatic cancer: current and future perspectives
John P. Neoptolemos et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
ECD promotes gastric cancer metastasis by blocking E3 ligase ZFP91-mediated hnRNP F ubiquitination and degradation
Song-Hui Xu et al.
CELL DEATH & DISEASE (2018)
Nucleus-Targeted, Echogenic Polymersomes for Delivering a Cancer Sternness Inhibitor to Pancreatic Cancer Cells
Fataneh Karandish et al.
BIOMACROMOLECULES (2018)
Phase 1b/2 trial of cancer stemness inhibitor napabucasin (NAPA) plus nab-paclitaxel (nPTX) and gemcitabine (Gem) in metastatic pancreatic adenocarcinoma (mPDAC).
Tanios S. Bekaii-Saab et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Inhibition of STAT3 blocks protein synthesis and tumor metastasis in osteosarcoma cells
Dongqing Zuo et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
A Chemoproteomic Approach to Query the Degradable Kinome Using a Multi-kinase Degrader
Hai-Tsang Huang et al.
CELL CHEMICAL BIOLOGY (2018)
Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead
Daniel P. Bondeson et al.
CELL CHEMICAL BIOLOGY (2018)
Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance
Jemilat Salami et al.
COMMUNICATIONS BIOLOGY (2018)
Structural basis of PROTAC cooperative recognition for selective protein degradation
Morgan S. Gadd et al.
NATURE CHEMICAL BIOLOGY (2017)
pSILAC mass spectrometry reveals ZFP91 as IMiD-dependent substrate of the CRL4CRBN ubiquitin ligase
Jian An et al.
NATURE COMMUNICATIONS (2017)
Targeted Protein Degradation: from Chemical Biology to Drug Discovery
Philipp M. Cromm et al.
CELL CHEMICAL BIOLOGY (2017)
A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase
Mary E. Matyskiela et al.
NATURE (2016)
Structural basis of lenalidomide-induced CK1α degradation by the CRL4CRBN ubiquitin ligase
Georg Petzold et al.
NATURE (2016)
PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer
Kanak Raina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Inhibitory effect of RNA-mediated knockdown of zinc finger protein 91 pseudogene on pancreatic cancer cell growth and invasion
Weiyi Huang et al.
ONCOLOGY LETTERS (2016)
Zinc finger protein 91 (ZFP91) activates HIF-1α via NF-κB/p65 to promote proliferation and tumorigenesis of colon cancer
Juan Ma et al.
ONCOTARGET (2016)
Deoxynyboquinones as NQO1-Activated Cancer Therapeutics
Elizabeth I. Parkinson et al.
ACCOUNTS OF CHEMICAL RESEARCH (2015)
Suppression of cancer relapse and metastasis by inhibiting cancer stemness
Youzhi Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
MultiNotch MS3 Enables Accurate, Sensitive, and Multiplexed Detection of Differential Expression across Cancer Cell Line Proteomes
Graeme C. McAlister et al.
ANALYTICAL CHEMISTRY (2014)
Small-Molecule Control of Intracellular Protein Levels through Modulation of the Ubiquitin Proteasome System
Dennis L. Buckley et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4CRBN
Anita K. Gandhi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
A sensitive and robust HPLC assay with fluorescence detection for the quantification of pomalidomide in human plasma for pharmacokinetic analyses
Shandiz Shahbazi et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2014)
STAT3 interrupts ATR-Chk1 signaling to allow oncovirus-mediated cell proliferation
Siva Koganti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
Jan Kroenke et al.
SCIENCE (2014)
Small Molecule Inhibitors of Signal Transducer and Activator of Transcription 3 (Stat3) Protein
Bikash Debnath et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
An Atypical E3 Ligase Zinc Finger Protein 91 Stabilizes and Activates NF-κB-inducing Kinase via Lys63-linked Ubiquitination
Xuejun Jin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Molecular dynamics simulations of the conformational changes in signal transducers and activators of transcription, Stat1 and Stat3
Jianping Lin et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2009)
Bortezomib up-regulates activated signal transducer and activator of transcription-3 and synergizes with inhibitors of signal transducer and activator of transcription-3 to promote head and neck squamous cell carcinoma cell death
Changyou Li et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Development of a STAT3 reporter prostate cancer cell line for high throughput screening of STAT3 activators and inhibitors
My N. Chau et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
STAT3 as a central mediator of neoplastic cellular transformation
David A. Frank
CANCER LETTERS (2007)
STAT proteins: novel molecular targets for cancer drug discovery
J Turkson et al.
ONCOGENE (2000)
Share Paper
